Haier’s HCH Ventures Partners with RF Imaging Leader Vayyar to Establish Joint Venture in China
QINGDAO, China and YEHUD, Israel, Oct. 27, 2021 /PRNewswire/ -- HCH, a subsidiary of Haier, has partnered with Vayyar, the Israeli high-tech...
News
RepliCel Announces Dermal Injector Update
Testing progresses to next-phase; results lead to some component upgrades to ensure optimal performance, quality compliance, and commercial-scale production capabilitiesVANCOUVER,...
Relief Therapeutics’ Wholly Owned Subsidiary, APR Applied Pharma Research, Reports Positive Interim Data from Its Clinical Trial of Novel Nasal Spray Sentinox in SARS-CoV-2 Infected Patients
Results Confirm the Safety and Tolerability of Sentinox and Suggest It Could Be Effective in Reducing Time to Negativization in...
Senseonics Holdings, Inc. Schedules Third Quarter 2021 Earnings Release and Conference Call for November 9, 2021, at 4:30 p.m. Eastern Time
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable...
Montreal Run For Ovarian Cancer Raises Over $130K For Early Detection Test
MONTREAL, QC/ ACCESSWIRE / October 26, 2021 / The Cedars Cancer Foundation is proud to announce that the 6th Annual...
Evotec SE: Announces Launch of Public Offering of American Depositary Shares
HAMBURG, GERMANY / ACCESSWIRE / October 26, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today...
Mindray’s Newest Ultrasound Machine Expands the Possibilities for Point of Care
MAHWAH, N.J., Oct. 26, 2021 /PRNewswire/ -- Mindray North America, a leading developer, manufacturer and supplier of medical devices, today announced...
Secarna Pharmaceuticals and Denali Therapeutics Expand Strategic Partnership for the Discovery and Development of Novel ASO Therapeutics in the Field of CNS Diseases
Companies broaden use of Secarna's industry-leading ASO discovery and development platform LNAplus TM and Denali's blood-brain barrier Transport Vehicle (TV)...
Aptevo Therapeutics Reports in the Refereed Medical Journal Cancers That the Risk of Cytokine Release Syndrome Is Low for Blood Cancer Patients Treated With Its Bispecific Antibody APVO436
SEATTLE, WA / ACCESSWIRE / October 26, 2021 / Aptevo Therapeutics Inc. ("Aptevo" or "the Company") (NASDAQ:APVO), a clinical-stage biotechnology...
Sparta Adopts Payment Platform To Advance Uptake of Its Cleantech Energy Technologies
TORONTO, ON / ACCESSWIRE / October 26, 2021 / Sparta Group (TSXV: SAY) (the "Corporation" the "Company", "Sparta Group", "Sparta...
9 Meters Biopharma, Inc. Presents Pharmacokinetic Data from Phase 1b/2a Study with Vurolenatide, Currently in Phase 2 for Short Bowel Syndrome, at the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting
- Vurolenatide's half-life is consistent with twice-monthly dosing -- Top-line results from the ongoing Phase 2 VIBRANT trial on track...
Rapid Therapeutic Science Laboratories to Present at the Benzinga Global Small Cap Conference
DALLAS, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Rapid Therapeutics Science Laboratories (OTC: RTSL) ("Rapid Therapeutic'' or the "Company"), a growth-oriented...
Forza Innovations Inc. Secures $3,000,000 Equity Line of Credit Financing
Calgary, Alberta, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forza Innovations Inc. (OTC Pink: FORZ) (the “Company”) is...
Shineco, Inc. Explores Medical Aesthetic Industry by Entering into MOU with Dragon Pride Limited
BEIJING, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2021
Salt Lake City, Utah, Oct. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- The third calendar quarter (3Q) of 2021...
Berkeley Lights Announces GSK Acquires Third Beacon® Optofluidic System to Expand Antibody Therapeutics Development
GSK adds antibody discovery workflow to current cell line development processEMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights,...
Neuronetics Celebrates 235,000 Treatment Milestone for Success TMS
The Company honors one of its largest providers for helping patients overcome depression with NeuroStar Advanced Therapy for Mental HealthMALVERN,...
180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules
PALO ALTO, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the...
Acer Therapeutics and Relief Therapeutics Announce Issuance of U.S. Patent 11,154,521 Covering ACER-001 Formulation
Key ACER-001 formulation composition of matter patent strengthens proprietary position in U.S. until 2036NEWTON, Mass. and GENEVA, Switzerland, Oct. 26,...
InspireMD to Report Third Quarter 2021 Financial Results on November 9, 2021 and Provide Corporate Business Update
Earnings Conference Call to be held Tuesday, November 9, 2021, at 8:30 a.m. ETTEL AVIV, Israel, Oct. 26, 2021 (GLOBE...